As a board-certified Pediatrician and a Pediatric Gastroenterologist, Dr. Hiremath is an internationally recognized leader in eosinophilic gastrointestinal diseases (EGIDs), bringing nearly fifteen years of clinical and research experience to advance patient care and scientific discovery.

At Vanderbilt, Dr. Hiremath directs the multidisciplinary Pediatric EGID program, a leading referral center for EGID patients across the Southern region. His clinic is dedicated to delivering evidence-based, compassionate care while addressing unique challenges faced by the children and families living with these complex conditions. Dr. Hiremath’s dedication to his patients and their families has earned him accolades, such as the Health Care Hero Award from Vanderbilt’s Friends of Children’s Hospital. Guided by meaningful interactions and shared decision-making, he identifies unmet needs that shape his translational research program.

Dr. Hiremath’s interdisciplinary translational research integrates pathology, allergy and immunology, biomedical engineering, computer science, industry partners, and patient care. As an active member of the NIH-funded Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) he collaborates with global leaders in the field. Grants from NIH, the American College of Gastroenterology, and institutional programs support his research. He has authored/ co-authored over 80 peer-reviewed manuscripts and has been invited to present at numerous national and international meetings. He is deeply committed to mentoring students, residents, and fellows and fostering the next generation of leaders.

>> View Publications on PubMed

Schematic illustration of the multidisciplinary clinical and research endeavors to advance the field of EGIDs (including EoE)